Results 21 to 30 of about 2,655 (189)

Vasoplegia: More Magic Bullets? [PDF]

open access: bronzeJournal of Cardiothoracic and Vascular Anesthesia, 2019
Ling Antonia Zeng, Nian Chih Hwang
openalex   +3 more sources

Induced mild hypothermia in post-cardiopulmonary bypass vasoplegia syndrome

open access: diamondAnnals of Cardiac Anaesthesia, 2009
The state of vasoplegia in immediate post-cardiopulmonary bypass period is characterized by severe hypotension, supranormal cardiac output, low systemic vascular resistance (SVR), and resistance to vasoconstrictors. We could successfully use induced mild hypothermia to increase SVR, and could avoid very high doses of nor-epinephrine (>0.3 mcg/kg/min ...
Mukesh Tripathi   +3 more
  +6 more sources

Uso do azul de metileno na reversão de vasoplegia refratária ao uso de catecolaminas após bypass aortobifemoral Use of methylene blue in the reversal of vasoplegia refractory to the use of catecholamines after aortobifemoral bypass

open access: greenJornal Vascular Brasileiro, 2010
Há evidências de que o óxido nítrico (NO) tem importância na vasodilatação associada a reações vasoplégicas. O objetivo deste relato de caso é documentar um caso de vasoplegia refratária ao uso de catecolaminas após bypass aortobifemoral revertida com o ...
Mariana Raphaela Garcia de Araújo dos Santos   +4 more
doaj   +1 more source

Circulating biomarkers of vasoplegia: a systematic review. [PDF]

open access: yesAnn Intensive Care
Abstract Background Vasoplegia is characterised by persistent hypotension and reduced systemic vascular resistance despite preserved cardiac output, commonly arising in sepsis, following major surgery, and within systemic inflammatory responses.
Boyer N   +6 more
europepmc   +3 more sources

Angiotensin-II for vasoplegia following cardiac surgery

open access: yesPerfusion, 2023
Introduction The objective of this study was to describe the implementation and outcomes of a protocol outlining angiotensin-II utilization for vasoplegia following cardiac surgery. Methods This was a retrospective chart review at a single-center university hospital.
Andrew J Johnson   +4 more
openaire   +2 more sources

Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high-dose insulin therapy. [PDF]

open access: yesBr J Clin Pharmacol
Aims Amlodipine poisoning is a leading cause of cardiovascular medication‐related deaths, commonly managed with high‐dose insulin (HDI) therapy. However, HDI is a vasodilator that is counterproductive in managing vasoplegia. We aim to study HDI therapy in patients with hypotension following dihydropyridine calcium channel antagonist (CCA) overdose ...
Chan BSH   +3 more
europepmc   +2 more sources

Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting

open access: yesMethodist DeBakey Cardiovascular Journal, 2021
Patients experiencing vasoplegia, a type of distributive shock, have limited options when conventional vasopressors are not appropriate or sufficient.
William Sovic   +10 more
doaj   +1 more source

Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous‐Flow Left Ventricular Assist Devices

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background The presence of a durable left ventricular assist device (LVAD) is associated with increased risk of vasoplegia in the early postoperative period following heart transplantation (HT).
Rabea Asleh   +13 more
doaj   +1 more source

Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundVasoplegia is associated with adverse outcomes following cardiac surgery; however, its impact following left ventricular assist device implantation is largely unexplored.
Kristen M. Tecson   +11 more
doaj   +1 more source

Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies

open access: yesSAGE Open Medicine, 2020
Cardiovascular disease remains the leading cause of death in the United States, and cardiopulmonary bypass is a cornerstone in the surgical management of many related disease states.
Theresa J Barnes   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy